Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1990 Feb;45(2):140–146. doi: 10.1136/thx.45.2.140

Aids and the lung. 6-- Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.

R F Miller 1, D M Mitchell 1
PMCID: PMC462331  PMID: 2180108

Full text

PDF
140

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allegra C. J., Chabner B. A., Tuazon C. U., Ogata-Arakaki D., Baird B., Drake J. C., Simmons J. T., Lack E. E., Shelhamer J. H., Balis F. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1987 Oct 15;317(16):978–985. doi: 10.1056/NEJM198710153171602. [DOI] [PubMed] [Google Scholar]
  2. Brenner M., Ognibene F. P., Lack E. E., Simmons J. T., Suffredini A. F., Lane H. C., Fauci A. S., Parrillo J. E., Shelhamer J. H., Masur H. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis. 1987 Nov;136(5):1199–1206. doi: 10.1164/ajrccm/136.5.1199. [DOI] [PubMed] [Google Scholar]
  3. Crawford S. W., Schwartz D. A., Petersen F. B., Clark J. G. Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome. Am Rev Respir Dis. 1988 Mar;137(3):682–687. doi: 10.1164/ajrccm/137.3.682. [DOI] [PubMed] [Google Scholar]
  4. Donnelly H., Bernard E. M., Rothkotter H., Gold J. W., Armstrong D. Distribution of pentamidine in patients with AIDS. J Infect Dis. 1988 May;157(5):985–989. doi: 10.1093/infdis/157.5.985. [DOI] [PubMed] [Google Scholar]
  5. Fitzgerald W., Bevelaqua F. A., Garay S. M., Aranda C. P. The role of open lung biopsy in patients with the acquired immunodeficiency syndrome. Chest. 1987 May;91(5):659–661. doi: 10.1378/chest.91.5.659. [DOI] [PubMed] [Google Scholar]
  6. Foltzer M. A., Hannan S. E., Kozak A. J. Pneumocystis pneumonia: response to corticosteroids. JAMA. 1985 Feb 15;253(7):979–979. [PubMed] [Google Scholar]
  7. Friedman Y., Franklin C., Rackow E. C., Weil M. H. Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure. Chest. 1989 Oct;96(4):862–866. doi: 10.1378/chest.96.4.862. [DOI] [PubMed] [Google Scholar]
  8. Gazzard B. G. Pneumocystis carinii pneumonia and its treatment in patients with AIDS. J Antimicrob Chemother. 1989 Jan;23 (Suppl A):67–75. doi: 10.1093/jac/23.suppl_a.67. [DOI] [PubMed] [Google Scholar]
  9. Golden J. A., Sjoerdsma A., Santi D. V. Pneumocystis carinii pneumonia treated with alpha-difluoromethylornithine. A prospective study among patients with the acquired immunodeficiency syndrome. West J Med. 1984 Nov;141(5):613–623. [PMC free article] [PubMed] [Google Scholar]
  10. Hanson P. J., Collins J. V. AIDS and the lung. 1--AIDS, aprons, and elbow grease: preventing the nosocomial spread of human immunodeficiency virus and associated organisms. Thorax. 1989 Oct;44(10):778–783. doi: 10.1136/thx.44.10.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kales C. P., Murren J. R., Torres R. A., Crocco J. A. Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med. 1987 Aug;147(8):1413–1417. [PubMed] [Google Scholar]
  12. Kerby G. R., Mayer L. S., Pingleton S. K. Nocturnal positive pressure ventilation via nasal mask. Am Rev Respir Dis. 1987 Mar;135(3):738–740. doi: 10.1164/arrd.1987.135.3.738. [DOI] [PubMed] [Google Scholar]
  13. Kernbaum S., Masliah J., Alcindor L. G., Bouton C., Christol D. Phospholipase activities of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia. Br J Exp Pathol. 1983 Feb;64(1):75–80. [PMC free article] [PubMed] [Google Scholar]
  14. Kesten S., Rebuck A. S. Nasal continuous positive airway pressure in Pneumocystis carinii pneumonia. Lancet. 1988 Dec 17;2(8625):1414–1415. doi: 10.1016/s0140-6736(88)90597-1. [DOI] [PubMed] [Google Scholar]
  15. Luce J. M., Wachter R. M., Hopewell P. C. Intensive care of patients with the acquired immunodeficiency syndrome: time for a reassessment? Am Rev Respir Dis. 1988 Jun;137(6):1261–1263. doi: 10.1164/ajrccm/137.6.1261. [DOI] [PubMed] [Google Scholar]
  16. MacFadden D. K., Edelson J. D., Hyland R. H., Rodriguez C. H., Inouye T., Rebuck A. S. Corticosteroids as adjunctive therapy in treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet. 1987 Jun 27;1(8548):1477–1479. doi: 10.1016/s0140-6736(87)92219-7. [DOI] [PubMed] [Google Scholar]
  17. Maxfield R. A., Sorkin I. B., Fazzini E. P., Rapoport D. M., Stenson W. M., Goldring R. M. Respiratory failure in patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Crit Care Med. 1986 May;14(5):443–449. doi: 10.1097/00003246-198605000-00001. [DOI] [PubMed] [Google Scholar]
  18. Miller R. F., Godfrey-Faussett P., Semple S. J. Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Thorax. 1989 Jul;44(7):565–569. doi: 10.1136/thx.44.7.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Murray J. F., Felton C. P., Garay S. M., Gottlieb M. S., Hopewell P. C., Stover D. E., Teirstein A. S. Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med. 1984 Jun 21;310(25):1682–1688. doi: 10.1056/NEJM198406213102529. [DOI] [PubMed] [Google Scholar]
  20. Murray J. F., Garay S. M., Hopewell P. C., Mills J., Snider G. L., Stover D. E. NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis. 1987 Feb;135(2):504–509. doi: 10.1164/arrd.1987.135.2.504. [DOI] [PubMed] [Google Scholar]
  21. Rosen M. J., Tow T. W., Chuang M. T., Teirstein A. S. Prognosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med. 1984 Aug;101(2):276–276. doi: 10.7326/0003-4819-101-2-276_1. [DOI] [PubMed] [Google Scholar]
  22. Sattler F. R., Cowan R., Nielsen D. M., Ruskin J. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study. Ann Intern Med. 1988 Aug 15;109(4):280–287. doi: 10.7326/0003-4819-109-4-280. [DOI] [PubMed] [Google Scholar]
  23. Schein R. M., Fischl M. A., Pitchenik A. E., Sprung C. L. ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med. 1986 Dec;14(12):1026–1027. doi: 10.1097/00003246-198612000-00006. [DOI] [PubMed] [Google Scholar]
  24. Smith R. A., Kirby R. R., Gooding J. M., Civetta J. M. Continuous positive airway pressure (CPAP) by face mask. Crit Care Med. 1980 Sep;8(9):483–485. doi: 10.1097/00003246-198009000-00001. [DOI] [PubMed] [Google Scholar]
  25. Steinbrook R., Lo B., Tirpack J., Dilley J. W., Volberding P. A. Ethical dilemmas in caring for patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Nov;103(5):787–790. doi: 10.7326/0003-4819-103-5-787. [DOI] [PubMed] [Google Scholar]
  26. Stover D. E., White D. A., Romano P. A., Gellene R. A., Robeson W. A. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med. 1985 Mar;78(3):429–437. doi: 10.1016/0002-9343(85)90334-1. [DOI] [PubMed] [Google Scholar]
  27. Wachter R. M., Cooke M., Hopewell P. C., Luce J. M. Attitudes of medical residents regarding intensive care for patients with the acquired immunodeficiency syndrome. Arch Intern Med. 1988 Jan;148(1):149–152. [PubMed] [Google Scholar]
  28. Wachter R. M., Luce J. M., Hearst N., Lo B. Decisions about resuscitation: inequities among patients with different diseases but similar prognoses. Ann Intern Med. 1989 Sep 15;111(6):525–532. doi: 10.7326/0003-4819-111-6-525. [DOI] [PubMed] [Google Scholar]
  29. Wachter R. M., Luce J. M., Turner J., Volberding P., Hopewell P. C. Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis. 1986 Nov;134(5):891–896. doi: 10.1164/arrd.1986.134.5.891. [DOI] [PubMed] [Google Scholar]
  30. Yoneda K., Walzer P. D. Mechanism of pulmonary alveolar injury in experimental Pneumocystis carinii pneumonia in the rat. Br J Exp Pathol. 1981 Aug;62(4):339–346. [PMC free article] [PubMed] [Google Scholar]
  31. al-Saady N. M., Blackmore C. M., Bennett E. D. High fat, low carbohydrate, enteral feeding lowers PaCO2 and reduces the period of ventilation in artificially ventilated patients. Intensive Care Med. 1989;15(5):290–295. doi: 10.1007/BF00263863. [DOI] [PubMed] [Google Scholar]
  32. el-Sadr W., Sidhu G., Diamond G., Zuger A., Berman D., Simberkoff M. S., Rahal J. J. High-dose corticosteroids as adjunct therapy in severe Pneumocystis carinii pneumonia. AIDS Res. 1986 Fall;2(4):349–355. doi: 10.1089/aid.1.1986.2.349. [DOI] [PubMed] [Google Scholar]
  33. el-Sadr W., Simberkoff M. S. Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation. Am Rev Respir Dis. 1988 Jun;137(6):1264–1267. doi: 10.1164/ajrccm/137.6.1264. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES